Tag: A*STAR
-
Apriori Bio and A*STAR Infectious Diseases Labs Forge Strategic Partnership to Advance Next-Generation Influenza Vaccines
Strategic Partnership to Accelerate Next-Generation Influenza Vaccines Apriori Bio, a Flagship Pioneering company dedicated to developing prospective, variant-resilient vaccines, has announced a strategic collaboration with the Agency for Science, Technology and Research (A*STAR) Infectious Diseases Labs. This partnership aims to accelerate the discovery and development of next-generation influenza vaccines capable of addressing evolving strains and…
-
Apriori Bio and A*STAR Forge Strategic Partnership to Accelerate Next-Generation Influenza Vaccines
Groundbreaking Collaboration Set to Transform Influenza Vaccines Apriori Bio, a Flagship Pioneering company dedicated to developing prospective, variant-resilient vaccines, has announced a strategic partnership with the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR ID Labs). The alliance seeks to accelerate the discovery and development of next-generation influenza vaccines designed to offer broader…
-
Apriori Bio and A*STAR Infectious Diseases Labs Forge Partnership to Accelerate Next-Generation Influenza Vaccines
Strategic collaboration set to redefine influenza vaccine development The life sciences landscape received a notable boost as Apriori Bio, a Flagship Pioneering venture focused on variant-resilient vaccines, and the Agency for Science, Technology and Research (A*STAR) Infectious Diseases Labs announced a strategic partnership aimed at accelerating the development of next-generation influenza vaccines. Announced from Cambridge,…